Stock Research for KOOL

KOOL

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

KOOL Stock Chart & Research Data

The KOOL chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the KOOL chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


KOOL Due diligence Resources & Stock Charts

The KOOL stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View KOOL Detailed Price Forecast - CNN Money CNN View KOOL Detailed Summary - Google Finance
Yahoo View KOOL Detailed Summary - Yahoo! Finance Zacks View KOOL Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View KOOL Trends & Analysis - Trade-Ideas Barrons View KOOL Major Holders - Barrons
NASDAQ View KOOL Call Transcripts - NASDAQ Seeking View KOOL Breaking News & Analysis - Seeking Alpha
Spotlight View KOOL Annual Report - CompanySpotlight.com OTC Report View KOOL OTC Short Report - OTCShortReport.com
TradeKing View KOOL Fundamentals - TradeKing Charts View KOOL SEC Filings - Bar Chart
WSJ View Historical Prices for KOOL - The WSJ Morningstar View Performance/Total Return for KOOL - Morningstar
MarketWatch View the Analyst Estimates for KOOL - MarketWatch CNBC View the Earnings History for KOOL - CNBC
StockMarketWatch View the KOOL Earnings - StockMarketWatch MacroAxis View KOOL Buy or Sell Recommendations - MacroAxis
Bullish View the KOOL Bullish Patterns - American Bulls Short Pains View KOOL Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View KOOL Stock Mentions - StockTwits PennyStocks View KOOL Stock Mentions - PennyStockTweets
Twitter View KOOL Stock Mentions - Twitter Invest Hub View KOOL Investment Forum News - Investor Hub
Yahoo View KOOL Stock Mentions - Yahoo! Message Board Seeking Alpha View KOOL Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for KOOL - SECform4.com Insider Cow View Insider Transactions for KOOL - Insider Cow
CNBC View KOOL Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for KOOL - OTC Markets
Yahoo View Insider Transactions for KOOL - Yahoo! Finance NASDAQ View Institutional Holdings for KOOL - NASDAQ


Stock Charts

FinViz View KOOL Stock Insight & Charts - FinViz.com StockCharts View KOOL Investment Charts - StockCharts.com
BarChart View KOOL Stock Overview & Charts - BarChart Trading View View KOOL User Generated Charts - Trading View


Latest Financial News for KOOL

Blog Exposure - AcelRx Pharma Completes the Human Factors Study for DSUVIA
Posted on Wednesday April 18, 2018

LONDON, UK / ACCESSWIRE / April 18, 2018 / Active-Investors.com has just released a free research report on AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) ("AcelRx").If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=ACRX as the Company's latest news hit the wire. On April 16, 2018, the specialty pharmaceutical Company, which is focused on the development and commercialization of innovative therapies for the treatment of acute pain, declared the successful completion of the human factor study to validate the effectiveness of the revised DSUVIA directions for use (DFU).


Has Cesca Therapeutics Inc (NASDAQ:KOOL) Improved Earnings Growth In Recent Times?
Posted on Tuesday April 17, 2018

When Cesca Therapeutics Inc (NASDAQ:KOOL) announced its most recent earnings (31 December 2017), I did two things: looked at its past earnings track record, then look at what is happeningRead More...


Cesca Therapeutics Announces First Evaluation Agreement With a Leading U.S. Academic Research Institution for X-Series™ Products That Provide Automated, Closed System Cellular Processing
Posted on Tuesday April 17, 2018

RANCHO CORDOVA, Calif., April 17, 2018-- Cesca Therapeutics Inc., a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that it has entered into ...


Cesca Therapeutics Inc. Announces Release of X-Mini™ Cell Selection Kit for the CAR-T Research Market
Posted on Tuesday April 03, 2018

RANCHO CORDOVA, Calif., April 03, 2018-- Cesca Therapeutics Inc., a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced the release of the X-Mini ...


Enter a stock symbol to view the stock details.